Alexander Nowak
Stock Analyst at Craig-Hallum
(2.71)
# 1,878
Out of 5,124 analysts
46
Total ratings
45.95%
Success rate
7.12%
Average return
Main Sectors:
Stocks Rated by Alexander Nowak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CELC Celcuity | Maintains: Buy | $96 → $108 | $99.74 | +8.28% | 3 | Nov 13, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $20 → $22 | $7.10 | +209.86% | 5 | Jan 17, 2025 | |
| NTRA Natera | Maintains: Buy | $121 → $157 | $229.09 | -31.47% | 4 | Nov 13, 2024 | |
| BVS Bioventus | Maintains: Buy | $12 → $17 | $7.44 | +128.49% | 6 | Sep 27, 2024 | |
| QDEL QuidelOrtho | Upgrades: Buy | $40 → $57 | $28.56 | +99.58% | 6 | Sep 5, 2024 | |
| CDNA CareDx | Upgrades: Buy | $12 → $15 | $18.84 | -20.38% | 3 | May 1, 2024 | |
| DMAC DiaMedica Therapeutics | Assumes: Buy | $8 | $7.96 | +0.50% | 4 | Apr 24, 2024 | |
| LUNG Pulmonx | Initiates: Buy | $18 | $2.21 | +714.48% | 1 | Sep 5, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $74 → $50 | $21.98 | +127.48% | 2 | Jun 13, 2023 | |
| DRIO DarioHealth | Maintains: Buy | $280 → $160 | $11.38 | +1,305.98% | 1 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $101.56 | - | 1 | Oct 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.76 | - | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $2.30 | +378.26% | 1 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $110 | $58.81 | +87.04% | 3 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | n/a | $5.52 | - | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $300 | $2.03 | +14,678.33% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $8.97 | +212.15% | 1 | Aug 31, 2020 |
Celcuity
Nov 13, 2025
Maintains: Buy
Price Target: $96 → $108
Current: $99.74
Upside: +8.28%
CVRx, Inc.
Jan 17, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $7.10
Upside: +209.86%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $121 → $157
Current: $229.09
Upside: -31.47%
Bioventus
Sep 27, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $7.44
Upside: +128.49%
QuidelOrtho
Sep 5, 2024
Upgrades: Buy
Price Target: $40 → $57
Current: $28.56
Upside: +99.58%
CareDx
May 1, 2024
Upgrades: Buy
Price Target: $12 → $15
Current: $18.84
Upside: -20.38%
DiaMedica Therapeutics
Apr 24, 2024
Assumes: Buy
Price Target: $8
Current: $7.96
Upside: +0.50%
Pulmonx
Sep 5, 2023
Initiates: Buy
Price Target: $18
Current: $2.21
Upside: +714.48%
Tandem Diabetes Care
Jun 13, 2023
Maintains: Buy
Price Target: $74 → $50
Current: $21.98
Upside: +127.48%
DarioHealth
May 12, 2023
Maintains: Buy
Price Target: $280 → $160
Current: $11.38
Upside: +1,305.98%
Oct 19, 2022
Downgrades: Hold
Price Target: n/a
Current: $101.56
Upside: -
Mar 28, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.76
Upside: -
Jan 5, 2022
Initiates: Buy
Price Target: $11
Current: $2.30
Upside: +378.26%
Feb 3, 2021
Maintains: Buy
Price Target: $88 → $110
Current: $58.81
Upside: +87.04%
Jan 20, 2021
Downgrades: Sell
Price Target: n/a
Current: $5.52
Upside: -
Jan 11, 2021
Initiates: Buy
Price Target: $300
Current: $2.03
Upside: +14,678.33%
Aug 31, 2020
Initiates: Buy
Price Target: $28
Current: $8.97
Upside: +212.15%